Aspen Pharmacare
Aspen Pharmacare to pay £8 million after colluding to rip off NHS
August 14, 2019Research and Development Addison's disease, Aspen Pharmacare, CMA, NHS, pharma
South African firm Aspen Pharmacare has agreed to pay £8 million to Britain’s NHS over a dispute about overpayment. The …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
